Apricus Biosciences Announces Podium Presentation of Efficacy and Clinical Safety Data for Vitaros at the European Sexual Society Medicine Conference

by Benzinga Staff
November 30, 2011 9:43 AM | 16 seconds read | Make a Comment

27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.

Apricus Biosciences, Inc. (Nasdaq: APRI) announced today the selection of an oral podium presentation on Vitaros® entitled, "Efficacy and Safety of Topical Aprostadil Cream (Vitaros®) in Hypertensive, Diabetic and Cardiac Patients with Male Erectile Dysfunction," at the European Society of Sexual Medicine conference, taking place in Milan, Italy on December 1-4, 2011.

27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: NewsFDA

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.